Search research articles
Contact Us
Filters
Showing results (31-40 of 58) with videos related to
Page
of 6
Sort By:
Blood Cancer Journal
|
March 1, 2020
Mass spectrometry-based identification of a B-cell maturation antigen-derived T-cell epitope for antigen-specific immunotherapy of multiple myeloma
Tatjana Bilich, Annika Nelde, Jens Bauer, et al.
Frontiers in Oncology
|
April 12, 2024
FusionVAC22_01: a phase I clinical trial evaluating a DNAJB1-PRKACA fusion transcript-based peptide vaccine combined with immune checkpoint inhibition for fibrolamellar hepatocellular carcinoma and other tumor entities carrying the oncogenic driver fusion
Christopher Hackenbruch, Jens Bauer, Jonas S Heitmann, et al.
Science Translational Medicine
|
March 16, 2021
T cell and antibody kinetics delineate SARS-CoV-2 peptides mediating long-term immune responses in COVID-19 convalescent individuals
Tatjana Bilich, Annika Nelde, Jonas S Heitmann, et al.
Blood Advances
|
December 21, 2023
Identification of novel canonical and cryptic HCMV-specific T-cell epitopes for HLA-A∗03 and HLA-B∗15 via peptide-PRISM
Alice Felicitas Rein, Chris David Lauruschkat, Ihsan Muchsin, et al.
Vaccines
|
April 30, 2021
Designing a SARS-CoV-2 T-Cell-Inducing Vaccine for High-Risk Patient Groups
Hans-Georg Rammensee, Cécile Gouttefangeas, Sonja Heidu, et al.
The Journal of Experimental Medicine
|
December 24, 2019
Identification of HCMV-derived T cell epitopes in seropositive individuals through viral deletion models
Maren Lübke, Stefanie Spalt, Daniel J Kowalewski, et al.
Journal for Immunotherapy of Cancer
|
April 15, 2025
PCI-DB: a novel primary tissue immunopeptidome database to guide next-generation peptide-based immunotherapy development
Steffen Lemke, Marissa L Dubbelaar, Patrick Zimmermann, et al.
Oncoimmunology
|
April 14, 2017
HLA class I-restricted <i>MYD88</i> L265P-derived peptides as specific targets for lymphoma immunotherapy
Annika Nelde, Juliane Sarah Walz, Daniel Johannes Kowalewski, et al.
ACS Infectious Diseases
|
March 16, 2021
Multiplexed Serum Antibody Screening Platform Using Virus Extracts from Endemic <i>Coronaviridae</i> and SARS-CoV-2
Simon Fink, Felix Ruoff, Aaron Stahl, et al.
Genome Medicine
|
April 2, 2020
Integrative -omics and HLA-ligandomics analysis to identify novel drug targets for ccRCC immunotherapy
Anna Reustle, Moreno Di Marco, Carolin Meyerhoff, et al.
Page
of 6
Search research articles
Search
Showing results (31-40 of 58) with videos related to
Sort By:
Page
of 6
Blood Cancer Journal
|
March 1, 2020
Mass spectrometry-based identification of a B-cell maturation antigen-derived T-cell epitope for antigen-specific immunotherapy of multiple myeloma
Tatjana Bilich, Annika Nelde, Jens Bauer, et al.
Frontiers in Oncology
|
April 12, 2024
FusionVAC22_01: a phase I clinical trial evaluating a DNAJB1-PRKACA fusion transcript-based peptide vaccine combined with immune checkpoint inhibition for fibrolamellar hepatocellular carcinoma and other tumor entities carrying the oncogenic driver fusion
Christopher Hackenbruch, Jens Bauer, Jonas S Heitmann, et al.
Science Translational Medicine
|
March 16, 2021
T cell and antibody kinetics delineate SARS-CoV-2 peptides mediating long-term immune responses in COVID-19 convalescent individuals
Tatjana Bilich, Annika Nelde, Jonas S Heitmann, et al.
Blood Advances
|
December 21, 2023
Identification of novel canonical and cryptic HCMV-specific T-cell epitopes for HLA-A∗03 and HLA-B∗15 via peptide-PRISM
Alice Felicitas Rein, Chris David Lauruschkat, Ihsan Muchsin, et al.
Vaccines
|
April 30, 2021
Designing a SARS-CoV-2 T-Cell-Inducing Vaccine for High-Risk Patient Groups
Hans-Georg Rammensee, Cécile Gouttefangeas, Sonja Heidu, et al.
The Journal of Experimental Medicine
|
December 24, 2019
Identification of HCMV-derived T cell epitopes in seropositive individuals through viral deletion models
Maren Lübke, Stefanie Spalt, Daniel J Kowalewski, et al.
Journal for Immunotherapy of Cancer
|
April 15, 2025
PCI-DB: a novel primary tissue immunopeptidome database to guide next-generation peptide-based immunotherapy development
Steffen Lemke, Marissa L Dubbelaar, Patrick Zimmermann, et al.
Oncoimmunology
|
April 14, 2017
HLA class I-restricted <i>MYD88</i> L265P-derived peptides as specific targets for lymphoma immunotherapy
Annika Nelde, Juliane Sarah Walz, Daniel Johannes Kowalewski, et al.
ACS Infectious Diseases
|
March 16, 2021
Multiplexed Serum Antibody Screening Platform Using Virus Extracts from Endemic <i>Coronaviridae</i> and SARS-CoV-2
Simon Fink, Felix Ruoff, Aaron Stahl, et al.
Genome Medicine
|
April 2, 2020
Integrative -omics and HLA-ligandomics analysis to identify novel drug targets for ccRCC immunotherapy
Anna Reustle, Moreno Di Marco, Carolin Meyerhoff, et al.
Page
of 6